In addition, it has been demonstrated that Fas, a marker of progesterone, estrogen receptors, and apoptosis, was suppressed in endometriosis cases in which LNG-IUS was administered and that this treatment contributed to the antiproliferative effect [46]. Here, FAS is linked to endometriosis.